StartsideNHIQ • OTCMKTS
add
NantHealth Inc
Forrige sluttkurs
0,00010 $
Dagsintervall
0,00010 $ - 0,00010 $
Markedsverdi
2,75k USD
Gjennomsnittlig volum
187,00
P/E-tall
-
Utbytte
-
Hovedbørs
OTCMKTS
Markedsnyheter
Økonomi
Resultatregnskap
Omsetning
Nettoomsetning
| (USD) | sep. 2023info | Endring år til år |
|---|---|---|
Omsetning | 12,47 mill. | — |
Driftskostnader | 12,17 mill. | — |
Nettoomsetning | −14,99 mill. | — |
Netto resultatmargin | −120,20 | — |
Fortjeneste per aksje | — | — |
EBITDA | −175,00k | — |
Faktisk avgiftssats | −0,36 % | — |
Balanseregnskap
Totale aktiva
Totale passiva
| (USD) | sep. 2023info | Endring år til år |
|---|---|---|
Kontant / kortsiktige inv. | 5,82 mill. | — |
Totale aktiva | 146,48 mill. | — |
Totale passiva | 396,66 mill. | — |
Total egenkapital | −250,18 mill. | — |
Utestående aksjer | 27,47 mill. | — |
P/B-forhold | −0,00 | — |
Avkastning på aktiva | −8,24 % | — |
Avkastning på kapital | −41,68 % | — |
Kontantstrøm
Netto kontantstrøm
| (USD) | sep. 2023info | Endring år til år |
|---|---|---|
Nettoomsetning | −14,99 mill. | — |
Kontantstrøm fra drift | −7,65 mill. | — |
Kontanter fra investering | 11,00k | — |
Kontanter fra finansiering | 7,50 mill. | — |
Netto kontantstrøm | −298,00k | — |
Fri kontantstrøm | −3,94 mill. | — |
Om
NantHealth, Inc. is a provider of software solutions for the healthcare industry, including NaviNet for insurance companies and decision support systems targeted at healthcare. The publicly traded company is headquartered in Winterville, North Carolina.
The company was founded by Patrick Soon-Shiong. His investment portfolio NantWorks controlled 62% of the voting shares of NantHealth at the end of 2021. Other notable early investors included Allscripts, BlackBerry, Kuwait Investment Authority, Celgene, and Verizon.
In September 2014, NantHealth was featured as the cover story in Forbes Magazine, which estimated NantHealth's market capitalization at $1.6 billion. In December 2014, NantHealth was featured on 60 Minutes by Sanjay Gupta. In August 2017, NantHealth signed a distribution agreement for GPS Cancer with Asia Genomics.
In January 2019, NantHealth received a delisting warning from Nasdaq "because the Company’s common stock failed to maintain a minimum closing bid price of $1.00 for 30 consecutive business days." At the time, the market value of the company was approximately $57m. The company made a 1-for-15 reverse stock split in December, 2022. Wikipedia
Administrerende direktør
Grunnlagt
7. juli 2010
Nettsted
Ansatte
373
